Global Nanomaterials in Personalized Medicine Market 2022 - Snapshot

September 2022 | 32 pages | ID: G24C3331EE87EN
Gen Consulting Company

Abstracts

The global nanomaterials in personalized medicine market size is projected to grow by USD 229 billion from 2022 to 2028, registering a CAGR of 9.8 percent, according to a new report by Gen Consulting Company.

This industry report offers market estimates of the global market, followed by a detailed analysis of the product, and region. The global market data on nanomaterials in personalized medicine can be segmented by product: gold nanoparticles, liposomes, monoclonal antibodies, nanocrystals, proteins, quantum dots. The proteins segment is estimated to account for the largest share of the global nanomaterials in personalized medicine market. Nanomaterials in personalized medicine market is further segmented by region: Asia Pacific, Europe, North America, Rest of the World (RoW).

The global nanomaterials in personalized medicine market is highly competitive. The prominent players operating in the global nanomaterials in personalized medicine market include Abraxis BioScience Inc., Bristol-Myers Squibb Company (BMS), Camurus AB, Eisai Co. Ltd., Johnson & Johnson, Merck & Co. Inc., NanoCarrier Co. Ltd., Novartis AG.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?

• Get a detailed picture of the Global Nanomaterials in Personalized Medicine Market
• Identify segments/areas to invest in over the forecast period in the Global Nanomaterials in Personalized Medicine Market
• Understand the competitive environment, the market’s leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. SUMMARY

PART 2. INTRODUCTION

Study period
Geographical scope
Market segmentation

PART 3. NANOMATERIALS IN PERSONALIZED MEDICINE MARKET OVERVIEW

PART 4. MARKET BREAKDOWN BY PRODUCT

Gold nanoparticles
Liposomes
Monoclonal antibodies
Nanocrystals
Proteins
Quantum dots

PART 5. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 6. KEY COMPANIES

Abraxis BioScience, Inc.
Bristol-Myers Squibb Company (BMS)
Camurus AB
Eisai Co., Ltd.
Johnson & Johnson
Merck & Co., Inc.
NanoCarrier Co., Ltd.
Novartis AG

PART 7. METHODOLOGY